Brian PharmD - Pardes Biosciences Chief Officer
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Insider
Brian PharmD is Chief Officer of Pardes Biosciences
| Age | 50 |
| Phone | 415 649 8758 |
| Web | https://www.pardesbio.com |
Pardes Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.2649) % which means that it has lost $0.2649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4028) %, meaning that it created substantial loss on money invested by shareholders. Pardes Biosciences' management efficiency ratios could be used to measure how well Pardes Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kenneth JD | Century Therapeutics | N/A | |
| BS CMAR | Champions Oncology | N/A | |
| Christopher Ogden | CytomX Therapeutics | 40 | |
| Stacy Markel | Nuvation Bio | 59 | |
| David MD | Nuvation Bio | 54 | |
| SPHR SHRMSCP | Ovid Therapeutics | N/A | |
| Claude MD | Ovid Therapeutics | 71 | |
| Michele Anderson | Assembly Biosciences | N/A | |
| Jeffrey Rona | Ovid Therapeutics | 56 | |
| Sergio Quezada | Achilles Therapeutics PLC | 49 | |
| Sumita JD | Instil Bio | 50 | |
| Michael MBA | Champions Oncology | N/A | |
| Karl MD | Achilles Therapeutics PLC | 57 | |
| David MBA | Champions Oncology | 55 | |
| Oleg Nodelman | Nuvation Bio | 44 | |
| Mark Dudley | Instil Bio | N/A | |
| Nicole White | Assembly Biosciences | N/A | |
| Robert Bazemore | Nuvation Bio | 53 | |
| Timothy Moore | Instil Bio | 63 | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
| Andrew MBA | Shattuck Labs | 38 | |
Management Performance
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 |
Pardes Biosciences Leadership Team
Elected by the shareholders, the Pardes Biosciences' board of directors comprises two types of representatives: Pardes Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pardes. The board's role is to monitor Pardes Biosciences' management team and ensure that shareholders' interests are well served. Pardes Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pardes Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elizabeth JD, Gen Sec | ||
| Heidi CPA, Chief Officer | ||
| Dave Kuo, VP HR | ||
| Uri MD, Founder Director | ||
| Valdas Jurkauskas, VP Operations | ||
| Thomas Wiggans, CEO Chairman | ||
| Patrick OBrien, VP Relations | ||
| Sean Brusky, Chief Officer | ||
| Brian PharmD, Chief Officer | ||
| Ann Kwong, Ex Research |
Pardes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pardes Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Shares Owned By Insiders | 13.47 % | |||
| Shares Owned By Institutions | 72.05 % | |||
| Number Of Shares Shorted | 874.35 K | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Net Income | (96.63 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Transaction History View history of all your transactions and understand their impact on performance |